コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 g pKa values of 5.6 (phosphoserine) and 5.9 (phosphothreonine).
2 tified 32P-Tyr, [32P]phosphoserine, and [32P]phosphothreonine.
3 ree P-Tyr (5 mM) but not by phosphoserine or phosphothreonine.
4 residue but did not cleave phosphoserine or phosphothreonine.
5 strates because B55 displays selectivity for phosphothreonine.
6 many but not all cases specifies binding to phosphothreonine.
7 zen polypeptides, several of which contained phosphothreonine.
8 dition of phosphotyrosine, phosphoserine, or phosphothreonine.
9 and PH domains, respectively, bind ICP10 at phosphothreonines 117 and 141 and a WD40-like motif at p
12 ing an antibody that specifically recognizes phosphothreonine-231) and T-tau using ultra-high sensiti
14 th fetal bovine serum markedly increased the phosphothreonine 410 content of CAT zeta and stimulated
18 d phosphoserine 19, phosphothreonine 18, and phosphothreonine 9 efficiently with almost identical rat
19 Dianionic phosphothreonine induced strong phosphothreonine amide protection and downfield amide ch
21 ot discriminate between dephosphorylation of phosphothreonine and phosphoserine residues in synthetic
22 ytically active form of Cdc25A for efficient phosphothreonine and phosphotyrosine dephosphorylation.
24 ephosphorylate contiguous and semicontiguous phosphothreonine and phosphotyrosine on cyclin dependent
25 activation of the MAP kinases by hydrolyzing phosphothreonine and phosphotyrosine residues present in
28 solution Raman spectra of phosphoserine and phosphothreonine are assigned to the monobasic and dibas
32 as a 14-3-3 interaction with a phosphoserine/phosphothreonine at the C-termini of the target protein.
33 due was identified that sterically restricts phosphothreonine binding and is largely responsible for
34 ks the structural properties associated with phosphothreonine binding and thus most likely interacts
36 d synchronously inactivate all phosphoserine/phosphothreonine-binding domain family members in a rapi
37 ytoplasmic regulatory module consisting of 2 phosphothreonine-binding Forkhead-associated domains joi
38 WW domain functioned as a phosphoserine- or phosphothreonine-binding module, with properties similar
39 e been well-characterized, phosphoserine- or phosphothreonine-binding modules have not been described
40 ysis of suppressors of a mutation in the Cdk phosphothreonine-binding pocket created by cyclin bindin
41 d Arg294 and Arg295 that likely comprise the phosphothreonine-binding pocket in PAC-1 to either alani
42 osphorylation by Clb2-Cdk1-Cks1 requires the phosphothreonine-binding site of Cks1, as well as a rece
43 N, inactivated Hog1 by dephosphorylating the phosphothreonine but not the phosphotyrosine residue in
44 racts are supershifted by phosphoserine- and phosphothreonine- but not phosphotyrosine-specific antib
47 ited a comparable substrate preference for a phosphothreonine containing substrate, consistent with t
49 ntation performs validation of phosphoserine/phosphothreonine-containing peptides having one or two p
50 inhibited Wip1 phosphatase activity, whereas phosphothreonine-containing peptides with the sequence p
55 Our observations suggest that phosphoserine/phosphothreonine-dependent localization is a key feature
56 achieving stereodivergence: peptide-embedded phosphothreonine-derived CPAs, which reinforce and ampli
57 2)-symmetric chiral phosphoric acids and (b) phosphothreonine-embedded, peptidic phosphoric acids.
58 horylation site contained a phosphoserine or phosphothreonine followed by a proline, suggesting that
60 tase 2A (PP2A) in vitro to dephosphorylate a phosphothreonine in a conserved TPNK sequence in the SLB
62 ion specificity of EYA1 in dephosphorylating phosphothreonine in Myc but also reveal an important mec
63 carbachol, leads to the rapid appearance of phosphothreonine in nonmuscle myosin heavy chain II-A (N
66 hat rWip1 dephosphorylates phosphoserine and phosphothreonine in the p(S/T)Q motif, which is an essen
69 ty for phosphotyrosine over phosphoserine or phosphothreonine is considerable, but the enzyme did not
70 exposed yet deep active site cleft while the phosphothreonine is loosely tethered into a nearby basic
71 ss spectrometry we demonstrate that SpvC has phosphothreonine lyase activity on full-length phospho-E
75 ue with a non-hydrolyzable the phosphoserine/phosphothreonine mimetic would promote binding to the 14
76 e diverse phosphoproteins, preferentially at phosphothreonine near acidic residues, near the protein
77 rylated by a kinase other than MEK1 and that phosphothreonines on Red1 then interact with the Mek1 FH
78 ne (Dhb) or dehydroalanine (Dha) in place of phosphothreonine or phosphoserine residues, respectively
80 blot analysis using anti-phosphoserine, anti-phosphothreonine, or anti-phosphotyrosine antibody to de
83 ore modeled on natural product inhibitors of phosphothreonine phosphatases, we generated a refined li
84 E technologies for installing phosphoserine, phosphothreonine, phosphotyrosine, and their mimics, dis
85 Pin1 binds specifically to phosphoserine- or phosphothreonine-proline (pS/T-P) motifs in target prote
86 ally recognizes the phosphoserine-proline or phosphothreonine-proline bonds present in mitotic phosph
87 PP2Calpha is a metal-dependent phosphoserine/phosphothreonine protein phosphatase and is the represen
90 yeast Rad53p, which is a naturally occurring phosphothreonine (pT)-binding domain, and found it to be
91 (Plk1) as a specific phosphoserine (pSer) or phosphothreonine (pThr) binding domain and determined it
92 iated (FHA) domains are modules that bind to phosphothreonine (pThr) residues in signaling cascades.
94 OL-derived chiral phosphoric acids (CPA) and phosphothreonine (pThr)-embedded peptides were found to
96 s mediated by an extended surface containing phosphothreonine recognition and hydrophobic interfaces
97 kinase A phosphorylation and the loss of the phosphothreonine residue and a major phosphopeptide that
98 f the enteropathogen Shigella to convert the phosphothreonine residue of the pT-X-pY consensus sequen
99 ally high pK values of the phosphoserine and phosphothreonine residues and the preference for a diani
100 PPPs) that dephosphorylate phosphoserine and phosphothreonine residues are increasingly understood as
102 mination of phosphate from phosphoserine and phosphothreonine residues followed by addition of an aff
103 l protein domains that bind phosphoserine or phosphothreonine residues have been identified, includin
104 phosphate moiety from both phosphoserine and phosphothreonine residues in low-energy collision-induce
105 sphorylates both the phosphotyrosine and the phosphothreonine residues in the activation loop of the
106 chemical transformation of phosphoserine and phosphothreonine residues into lysine analogs (aminoethy
108 addition and conversion of phosphoserine and phosphothreonine residues to S-ethylcysteinyl or beta-me
109 ical derivatization of the phosphoserine and phosphothreonine residues using stable isotopic variants
110 values for the presence of phosphoserine or phosphothreonine residues using tandem mass spectrometry
118 odies to O-linked GlcNAc, phosphoserine, and phosphothreonine showed that hyperglycemia increased Glc
119 ss-phosphorylating TRPM7 as assessed using a phosphothreonine-specific antibody but not vice versa.
120 g protein) and in BRCA1 as phosphoserine- or phosphothreonine-specific binding modules that recognize
122 CD0242 protein catalyses the addition of the phosphothreonine to the N-acetylglucosamine moiety and C
123 challenges by optimizing genetically encoded phosphothreonine translation to characterize phospho-dep
126 oncognate amino acids glutamate, serine, and phosphothreonine without the need for a separate hydroly